Table: Stella Pharma - Q1 parent results

Stella Pharma

07/08/2025 06:01

Aug 7 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2025        Jun 30, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            92 mln              61 mln             1.01      
                 (+50.0 pct)         (+0.0 pct)        (+4.8 pct)   
  Operating     loss 151 mln        loss 166 mln      loss 348 mln  
  Recurring     loss 155 mln        loss 161 mln      loss 345 mln  
  Net           loss 156 mln        loss 161 mln      loss 348 mln  
  EPS           loss 4.60 yen       loss 5.12 yen    loss 10.23 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T